Brief: Hester Biosciences June-Quarter Consol Net Profit Rises
12/08/2021 06:53
Aug 12 (Reuters) - Hester Biosciences Ltd HEST.NS :
* HESTER BIOSCIENCES JUNE-QUARTER CONSOL NET PROFIT 124.9 MILLION RUPEES VERSUS 57.2 MILLION
RUPEES YEAR AGO
* HESTER BIOSCIENCES JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 601.9 MILLION RUPEES VERSUS
398.5
MILLION RUPEES YEAR AGO
* HESTER BIOSCIENCES - ARRANGEMENT WITH BHARAT BIOTECH FOR MANUFACTURING DRUG SUBSTANCE FOR
COVAXIN IS PROGRESSING AS PER TIMELINE
Source text for Eikon: ID:nBSE2P2c5
Further company coverage: HEST.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hester Biosciences
See all newsIndia's Hester Biosciences jumps on quarterly profit rise
Brief: Hester Biosciences March-Quarter Consol Net Profit 159.8 Million Rupees
India's Hester Biosciences gains on plan to sell stake in Texas Lifesciences
Brief: Hester Biosciences Approves Divestment Of 43.81% Equity In Texas Lifesciences
Brief: Hester Biosciences Re-Appoints Rajiv Gandhi As CEO & MD